Skip to search formSkip to main contentSkip to account menu

iroxanadine

Known as: 5,6-dihydro-5-(1-piperidinyl)methyl-3-(3-pyridil)-4H-1,2,4-oxa-diazine, 5,6-dihydro-5-(1-piperidinyl)methyl-3-(3-pyridyl)-4H-1,2,4-oxadiazine, cytrx 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

BRX-235

Broader (2)

OxazinesPiperidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Pharmacological attenuation of apoptosis in reoxygenated endothelial cells
Abstract.BRX-235 (Iroxanadine), a novel drug developed by Biorex (Hungary), was previously characterized as a vasculoprotector… 
1999
1999
Flocor (CytRx Corp).
  • N. Modi
  • IDrugs : the investigational drugs journal
  • 1999
  • Corpus ID: 43869326
CytRx is developing Flocor, an amphipathic copolymer, as a potential treatment for acute sickle cell crisis and acute respiratory… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)